Jubilant Life Sciences soars on receiving ANDA approval for Felodipine ER Tablets

25 Aug 2016 Evaluate

Jubilant Life Sciences is currently trading at Rs. 527.60, up by 20.55 points or 4.05% from its previous closing of Rs. 507.05 on the BSE.

The scrip opened at Rs. 510.10 and has touched a high and low of Rs. 533.70 and Rs. 510.10 respectively. So far 72,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 533.70 on 25-Aug-2016 and a 52 week low of Rs. 261.00 on 08-Sep-2015.

Last one week high and low of the scrip stood at Rs. 533.70 and Rs. 486.85 respectively. The current market cap of the company is Rs. 8,377.00 crore.

The promoters holding in the company stood at 54.02%, while Institutions and Non-Institutions held 26.82% and 19.15% respectively.

Jubilant Life Sciences, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval for Felodipine Extended-Release Tablets USP, 2.5 mg, 5 mg, and 10 mg, the generic version of Plendil Tablets of AstraZeneca, which is used for the treatment of hypertension.

As on June 30, 2016, Jubilant Life Sciences had a total of 770 filings for Oral Solids of which 578 have been approved in various regions globally. This includes 70 ANDAs filed in the US, of which 44 have been approved and 104 filings in Europe.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.


Jubilant Pharmova Share Price

961.10 21.35 (2.27%)
28-Jan-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.05
Dr. Reddys Lab 1225.55
Cipla 1325.00
Zydus Lifesciences 896.15
Lupin 2131.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×